The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Satlin Andrew since year 2005.
The trader's CIK number is 1722858.
At the time of the last reporting, Satlin Andrew was the EVP and Chief Medical Officer of Intra-cellular Therapies, Inc. .
(stock ticker symbol ITCI).
See this page for all insider trading activities at Intra-cellular Therapies, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-09||ITCI||Intra-cellular Therapies, Inc.||Sale||11,573||26.16||302,749|
|2020-01-08||ITCI||Intra-cellular Therapies, Inc.||Option Ex||22,911||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Satlin Andrew (EVP and Chief Medical Officer of Intra-cellular Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.